Key Partners Key Activities Value Customer Customer Segments
Propositions Relationship
-Patient groups -Improve the lives -Asset sharing -Providers- Doctor
of patients with groups, Health Care -Academic groups rare diseases by -Making available Systems, Clinics empowering clinical-trial -Co-creation of -Biotech and patient groups and databases that -Pharmaceuticals- Mental value Pharmaceutical enabling them to record the Health, Cholesterol match drug effectiveness of -Europe based treatments. most drugs across -Patients- Chronic patient group therapeutic Diseases, Post-surgery Children’s Tumor areas and diseases care Foundation (CTF) including rare ones. Key Resources Channels -The business promised more -Collaborate with -Intellectual personalization by patient Capital revealing drugs with organizations to high potential for find and develop treating the rare new medications, disease covered. then take them through clinical trials and into the hands of patients. Cost Structure Revenue Streams -Licensing in: -Licensing out